Medication adherence to secondary prevention after ischemic cerebrovascular disease: a real-world outcomes analysis.

Stollberg SM, Signorell A, Luft AR, Huber CA

Open source

DOI
10.3389/fneur.2026.1764948
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1764948,
  title = {Medication adherence to secondary prevention after ischemic cerebrovascular disease: a real-world outcomes analysis.},
  author = {Stollberg SM and Signorell A and Luft AR and Huber CA},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1764948},
  url = {https://doi.org/10.3389/fneur.2026.1764948}
}

RIS

TY  - JOUR
TI  - Medication adherence to secondary prevention after ischemic cerebrovascular disease: a real-world outcomes analysis.
AU  - Stollberg SM
AU  - Signorell A
AU  - Luft AR
AU  - Huber CA
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1764948
UR  - https://doi.org/10.3389/fneur.2026.1764948
ER  - 

APA

SM, S., A, S., AR, L., & CA, H. (2026). Medication adherence to secondary prevention after ischemic cerebrovascular disease: a real-world outcomes analysis.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1764948

Source records